S. TÜRK Et Al. , "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment," 44th FEBS Congress , Krakow, Poland, 2019
TÜRK, S. Et Al. 2019. Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment. 44th FEBS Congress , (Krakow, Poland).
TÜRK, S., TÜRK, C., AKBAR, M., Okay, M., ERİKÇİ, A., SAYINALP, N., ... HAZNEDAROĞLU, İ. C.(2019). Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment . 44th FEBS Congress, Krakow, Poland
TÜRK, SEYHAN Et Al. "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment," 44th FEBS Congress, Krakow, Poland, 2019
TÜRK, SEYHAN Et Al. "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment." 44th FEBS Congress , Krakow, Poland, 2019
TÜRK, S. Et Al. (2019) . "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment." 44th FEBS Congress , Krakow, Poland.
@conferencepaper{conferencepaper, author={SEYHAN TÜRK Et Al. }, title={Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene based cancer biomarkers and the prediction of progrnosis and treatment}, congress name={44th FEBS Congress}, city={Krakow}, country={Poland}, year={2019}}